EC Number   |
Activating Compound |
Reference |
|---|
   3.1.3.9 | alamethicin |
- |
649740 |
| 3.1.3.9 | beta-naphthoflavone |
the activation in dependence on the age of rats is studied |
653110 |
| 3.1.3.9 | calyculin A |
activation of enzyme in supernatant and in intact or disrupted microsomes |
134950 |
| 3.1.3.9 | cAMP |
enzyme activation by cAMP depends on protein kinase A |
751406 |
| 3.1.3.9 | D-glucose |
elevated concentration, D-glucose may play a direct role as a stimulator of enzyme expression |
649729 |
| 3.1.3.9 | D-glucose |
induces the expression of G-6-Pase at transcriptional and posttranscriptional levels, strongly increases endogenous G-6-Pase mRNA levels in 832/13 cells and in rat pancreatic islets. Induced levels from islets are still markedly lower than in untreated primary hepatocytes |
677468 |
| 3.1.3.9 | deoxycholate |
- |
649740 |
| 3.1.3.9 | dexamethasone |
in cultured hepatoma cells |
649729 |
| 3.1.3.9 | dexamethasone |
the activation in dependence on the age of rats is studied |
653110 |
| 3.1.3.9 | forskolin |
forskolin treatment promotes a 70% stimulation of G6Pase activity. The increase in glucose-6-phosphate transporter activity is required for the stimulation of glucose-6-phosphatase activity by forskolin |
751406 |
